Session information

Poster Presentation

[28PO5-am1] Anatomy and physiology-2 Immune system and biological defense

Mon. Mar 28, 2022 9:00 AM - 10:40 AM [Room PO5] Bldgs. 2&3, 3F Passage (Bldgs. 2&3: 3F)

【説明時間】9:15～10:25

+Add all to schedule

9:00 AM - 10:40 AM

[28PO5-am1-01S] Production of artificial antibodies and determination of variable gene sequence of antibodies that recognize tumor-associated glycans

○Masahiro Yoshida¹, Yuki Inagaki¹, Yuki Hitomi¹, Teruaki Oku¹, Kaori Denda-Nagai², Tatsuro Irimura², Makoto Tsuiji¹ (1. Hoshi Univ., 2. Juntendo Univ.)

9:00 AM - 10:40 AM

[28PO5-am1-02] Expression of Coronin-1, an immune-specific actin-binding protein, in macrophages is regulated by chromatin accessibility of transcription factor Sp3

○Yusuke Ando¹, Yutaka Kaneko², Shinya Hasegawa², Makoto Tsuiji², Chie Watanabe¹, Teruaki Oku² (1. Fac. Pharm. Pharm. Sci., Josai Univ., 2. Hoshi Univ.)

9:00 AM - 10:40 AM

[28PO5-am1-03] Regualtion of LPS-induced NF-κB activation by ERK1/2 and p38 MAPK

○Kosuke Zenke^1,2, Nao Hasegawa¹, Sachiko Watanabe^1,2, Masashi Muroi^1,2 (1. Dept. Pharm., Musasino Univ., 2. Res. Inst. Pharm. Sci., Musashino Univ.)

9:00 AM - 10:40 AM

[28PO5-am1-04] A novel intramolecular regulation of mouse Jak3 activity by phosphorylation of a tyrosine 820

○Yuichi Sekine¹, Kazuna Kikkawa¹, Masahiro Fujimuro¹, Tadashi Matsuda² (1. Kyoto Pharm. Univ., 2. Grad. Sch. Pharm. Sci., Hokkaido Univ.)

9:00 AM - 10:40 AM

[28PO5-am1-05S] A TNFR2-selective and agonistic TNF mutein Fc-fusion protein suppresses contact hypersensitivity responses.

○Reira Ueno¹, Masaki Inoue^1,2, Keisuke Tanaka¹, Haruhiko Kamada², Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

9:00 AM - 10:40 AM

[28PO5-am1-06S] A TNFR2-selective agonistic TNF mutein suppressed inflammation in collagen-induced arthritis model mice.

○Daisuke Miyamoto¹, Masaki Inoue^1,2, Reira Ueno¹, Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

9:00 AM - 10:40 AM

[28PO5-am1-07S] Characterization of an anti-human BAFF receptor monoclonal antibody for therapeutic application.

○Yukiko Nabeshima¹, Masaki Inoue^1,2, Yasuhiro Abe³, Tomoko Ise², Satoshi Nagata², Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN, 3. NIHS)

9:00 AM - 10:40 AM

[28PO5-am1-08S] Evaluation of in vitro cellular cytotoxicity of a novel anti-human BAFF receptor monoclonal antibody toward B cell lymphoma.

○Yukiho Nakamura¹, Masaki Inoue^1,2, Yasuhiro Abe³, Tomoko Ise², Satoshi Nagata², Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN, 3. NIHS)

9:00 AM - 10:40 AM

[28PO5-am1-09S] Functions of aminopeptidase P3, an adaptor molecule for TNFR2, in Tregs and immune system.

○Keisuke Tanaka¹, Masaki Inoue^1,2, Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

9:00 AM - 10:40 AM

[28PO5-am1-10S] Pharmacological effects of TNFR1-selective antagonistic TNF mutant Fc-fusion protein for the arthritis mice.

○Yuka Moriyasu¹, Masaki Inoue^1,2, Haruhiko Kamada², Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

9:00 AM - 10:40 AM

[28PO5-am1-11S] Creation of immunocytokine as a potent stimulator of TNFR2 signaling.

○Yukina Kobashi¹, Masaki Inoue^1,2, Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

9:00 AM - 10:40 AM

[28PO5-am1-12S] Immunocytokine fused with TNFR2 agonist protein and TNFR2 scFv enhances TNFR2 signaling.

○Miyu Goto¹, Masaki Inoue^1,2, Shin-ichi Tsunoda^1,2 (1. Fac. Pharm. Sci., Kobe Gakuin Univ., 2. NIBIOHN)

Authentication

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Please log in with your participant account.
» Participant Log In

▲